Melanoma Therapeutics Market Size, Share and Forecast 2026
The Melanoma Therapeutics Market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. Skin cancer is of three types: basal cell carcinoma, squamous cell carcinoma, and melanoma. UV radiations from sunlight are the primary cause of melanoma. In certain cases, genes can also be cause for melanoma. According to the World Health Organization (WHO), about 132,000 melanoma skin cancers occur each year globally.
Market Dynamics:
The market is driven by the rising prevalence of melanoma, improvement in healthcare facilities, government initiatives and innovation of medicines with better efficiency. Lack of awareness of the disease and high cost associated with the therapy are going to hamper the market growth over the period of forecast.
Market Segmentation:
By Stage
• Stage 0
• Stage I
• Stage II
• Stage III
• Stage IV
By Therapy
• Surgery
• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Radiation Therapy
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Bristol-Myers Squibb Co. *
• Merck and Co., Inc.
• F. Hoffmann-La Roche, Ltd.
• AB Science S.A.
• Amgen, Inc.
• Celgene Corp.
• Others
View full report: https://www.datamintelligence.com/research-report/melanoma-therapeutics-market
Download free sample: https://www.datamintelligence.com/DOWNLOAD-SAMPLE/melanoma-therapeutics-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. Skin cancer is of three types: basal cell carcinoma, squamous cell carcinoma, and melanoma. UV radiations from sunlight are the primary cause of melanoma. In certain cases, genes can also be cause for melanoma. According to the World Health Organization (WHO), about 132,000 melanoma skin cancers occur each year globally.
Market Dynamics:
The market is driven by the rising prevalence of melanoma, improvement in healthcare facilities, government initiatives and innovation of medicines with better efficiency. Lack of awareness of the disease and high cost associated with the therapy are going to hamper the market growth over the period of forecast.
Market Segmentation:
By Stage
• Stage 0
• Stage I
• Stage II
• Stage III
• Stage IV
By Therapy
• Surgery
• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Radiation Therapy
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Bristol-Myers Squibb Co. *
• Merck and Co., Inc.
• F. Hoffmann-La Roche, Ltd.
• AB Science S.A.
• Amgen, Inc.
• Celgene Corp.
• Others
View full report: https://www.datamintelligence.com/research-report/melanoma-therapeutics-market
Download free sample: https://www.datamintelligence.com/DOWNLOAD-SAMPLE/melanoma-therapeutics-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results